|Bid||55.07 x 800|
|Ask||55.16 x 1000|
|Day's Range||54.93 - 56.78|
|52 Week Range||49.40 - 66.34|
|Beta (3Y Monthly)||1.33|
|PE Ratio (TTM)||70.27|
|Earnings Date||Jul 25, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||69.38|
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
SOUTH JORDAN, Utah, July 09, 2019 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in.
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of March. At Insider Monkey, we follow nearly 750 active hedge funds and notable investors and by analyzing their 13F filings, we can determine the stocks that they are […]
Challenging market conditions, especially in retail, causes a slowdown in the Retail Pharmacy International division at Walgreens Boots (WBA).
Nearly three years after taking its novel medical device to market in Europe, the Alamo City company is still working to clear U.S. regulatory roadblocks.
Brightwater Medical was founded by Dr. Robert Smouse, Professor of Radiology and Surgery, University of Illinois College of Medicine. Its primary product, the ConvertX®, is a single device used to replace a series of devices and procedures used to treat severe obstructions of the ureter. The system is designed to be implanted once and converted from a nephroureteral catheter to a nephroureteral stent without requiring sedation or local anesthesia. Brightwater Medical recently received FDA clearance for the ConvertX® biliary stent system. Over the next several months, Merit Medical intends to maintain Brightwater Medical’s production capabilities in Temecula while duplicating those capabilities in its catheter facility in Pearland, Texas, prior to transferring the ConvertX® manufacturing operations to its Pearland facility. Merit Medical’s management estimates that the transaction will be approximately $(0.05) decretive to earnings per share for the year ending December 31, 2019 on a GAAP basis and approximately $(0.03) decretive to earnings per share for the year ending December 31, 2019 on a non-GAAP basis due to deal-related expenses, severance, transfer and integration costs, and international regulatory expenses. Management’s current revenue expectations for the ConvertX® product for calendar year 2019 are approximately $1 million with expectations of growth to approximately $25 million in the fifth full year of sales. Upon transfer of the ConvertX® manufacturing operations to Merit’s Pearland facility, management believes non-GAAP gross margins in the 70-75% range are attainable.
Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies...
Merit Medical Systems Inc NASDAQ/NGS:MMSIView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for MMSI with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold MMSI had net inflows of $1.11 billion over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Merit Medical Systems, Inc. (MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it has been awarded a group purchasing agreement for interventional fluid management products with Premier. Effective July 1, 2019, this agreement provides for Premier members, at their discretion, to take advantage of negotiated commercial terms for Merit’s interventional fluid management portfolio of products. “Since our inception, our interventional fluid management products have been foundational to Merit's success and a key driver of our progress,” said Fred P. Lampropoulos, Merit Chairman and CEO.
SOUTH JORDAN, Utah, June 10, 2019 -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional,.
Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Merit Medical...
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Merit Medical Systems (MMSI), founded in 1987 by current CEO Fred Lampropoulos, is a leading manufacturer and marketer of proprietary disposable medical devices, notes growth stock expert Hilary Kramer, editor of GameChangers.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching Merit Medical Systems, Inc. (NASDAQ:MMSI) might want to consider the historical vo...